ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29 June 2024, as well as online, through a dedicated virtual platform. The congress will be the place to present impactful new data in GI oncology.
Teresa Macarulla, GI Medical Oncologist at the Vall d’Hebron Institute of Oncology, shared a few highlights from the conference.
Thomas Seufferlein reviews the role of personalised medicine in the PDAC
Educational session in ESMOGI24.
- NGS testing make sense, but is not the only means
- targeting KRAS may be a game changer
- importance of molecular tumor board
Florencia Mcallister in the PDAC educational session in ESMOGI24
Excellent presentation:
- PDAC universal genetic testing is the standard
- Importance of multi- institutional research effort for early detection projects in PDAC
Management of precancerous lesions in PDAC.
Maria Reig nicely reviewed treatment of localised tumours in the HCC educational session.
